Antisense Oligonucleotide Silencing Reverses Abnormal Neurochemistry in Spinocerebellar Ataxia 3 Mice
Annals of Neurology · 2023
DOI: 10.1002/ana.26713 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, 2023. Verfasst von Hayley S McLoughlin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Michigan, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Machado-Joseph Disease, Neurochemistry. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIBIB NIH HHS, NINDS NIH HHS, National Institute of Biomedical Imaging and Bioengineering.
Abstract (Originalsprache)
Objective
Spinocerebellar ataxia type 3 (SCA3) is the most common dominantly inherited ataxia, and biomarkers are needed to noninvasively monitor disease progression and treatment response. Anti‐ ATXN3 antisense oligonucleotide (ASO) treatment has been shown to mitigate neuropathology and rescue motor phenotypes in SCA3 mice. Here, we investigated whether repeated ASO administration reverses brainstem and cerebellar neurochemical abnormalities by magnetic resonance spectroscopy (MRS).
Methods
Symptomatic SCA3 mice received intracerebroventricular treatment of ASO or vehicle and were compared to wild‐type vehicle‐treated littermates. To quantify neurochemical changes in treated mice, longitudinal 9.4T MRS of cerebellum and brainstem was performed. Acquired magnetic resonance (MR) group means were analyzed by 2‐way analysis of variance mixed‐effects sex‐adjusted analysis with post hoc Sidak correlation for multiple comparisons. Pearson correlations were used to relate SCA3 pathology and behavior.
Results
MR spectra yielded 15 to 16 neurochemical concentrations in the cerebellum and brainstem. ASO treatment in SCA3 mice resulted in significant total choline rescue and partial reversals of taurine, glutamine, and total N ‐acetylaspartate across both regions. Some ASO‐rescued neurochemicals correlated with reduction in diseased protein and nuclear ATXN3 accumulation. ASO‐corrected motor activity correlated with total choline and total N ‐acetylaspartate levels early in disease.
Interpretation
SCA3 mouse cerebellar and brainstem neurochemical trends parallel those in patients with SCA3. Decreased total choline may reflect oligodendrocyte abnormalities, decreased total N ‐acetylaspartate highlights neuronal health disturbances, and high glutamine may indicate gliosis. ASO treatment fully or partially reversed select neurochemical abnormalities in SCA3 mice, indicating the potential for these measures to serve as noninvasive treatment biomarkers in future SCA3 gene silencing trials. ANN NEUROL 2023;94:658–671
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Michigan, Ann Arbor, MI, USA.
- Center for Magnetic Resonance Research, Department of Radiology, Medical School, University of Minnesota, Minneapolis, MN, USA.
- Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN, USA.
- Department of Neuroscience, University of Minnesota, Minneapolis, MN, USA.
- Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
ORCID-Profile: Hayley S McLoughlin, Gülin Öz
Förderung
- NIBIB NIH HHS
- NINDS NIH HHS
- National Institute of Biomedical Imaging and Bioengineering
- National Institute of Neurological Disorders and Stroke
- W. M. Keck Foundation
Zitieren
APA
McLoughlin, H. S., Gundry, K., Rainwater, O., Schuster, K. H., Wellik, I. G., Zalon, A. J., Benneyworth, M. A., Eberly, L. E., & Öz, G. (2023). Antisense Oligonucleotide Silencing Reverses Abnormal Neurochemistry in Spinocerebellar Ataxia 3 Mice. Annals of Neurology. https://doi.org/10.1002/ana.26713
Vancouver
McLoughlin HS, Gundry K, Rainwater O, Schuster KH, Wellik IG, Zalon AJ, et al. Antisense Oligonucleotide Silencing Reverses Abnormal Neurochemistry in Spinocerebellar Ataxia 3 Mice. Annals of Neurology. 2023. doi:10.1002/ana.26713
BibTeX
@article{McLoughlin2023,
author = {McLoughlin, Hayley S and Gundry, Katherine and Rainwater, Orion and Schuster, Kristen H and Wellik, Isabel G and Zalon, Annie J and Benneyworth, Michael A and Eberly, Lynn E and Öz, Gülin},
title = {Antisense Oligonucleotide Silencing Reverses Abnormal Neurochemistry in Spinocerebellar Ataxia 3 Mice},
journal = {Annals of Neurology},
year = {2023},
doi = {10.1002/ana.26713}
}
EUVIMED